|
Xenobiotic-Metabolizing Enzymes
|
ZIA BC 005562
|
$707,692
|
$353,846
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic Receptors
|
ZIA BC 005708
|
$707,692
|
$283,077
|
Gonzalez, Frank
|
CCR (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
$16,006
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Workshops On Viral Oncogenesis and Pathogenesis
|
5R13CA095919-11
|
$7,000
|
$1,050
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-05S2
|
$37,430
|
$374
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-05
|
$1,396,397
|
$13,964
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Widespread vs Selective Screening for Hepatitis B Infection Prior to Chemotherapy
|
1R21CA167202-01A1
|
$171,825
|
$171,825
|
Hwang, Jessica
|
UT MD ANDERSON CANCER CTR
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$52,897
|
$5,290
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-23S1
|
$125,000
|
$1,250
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-23
|
$431,709
|
$4,317
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validation of Therapeutic Target Genes in Human Liver Cancer
|
ZIA BC 011175
|
$265,729
|
$225,870
|
Thorgeirsson, Snorri
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-39
|
$4,133,528
|
$124,006
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S1
|
$37,429
|
$1,123
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S2
|
$122,414
|
$3,672
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using evolutionary analysis to prevent virally induced cancer
|
1F31CA180609-01
|
$35,308
|
$35,308
|
Maher, Cyrus
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIA BC 005673
|
$523,027
|
$52,303
|
Keefer, Larry
|
CCR (NCI)
|
|
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
|
5K07CA160722-03
|
$170,100
|
$170,100
|
Sanoff, Hanna
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S1
|
$12,500
|
$500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S2
|
$12,459
|
$498
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-38
|
$5,870,229
|
$234,809
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urban Health Study
|
ZIA CP005782-10067
|
$102,763
|
$102,763
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S1
|
$74,531
|
$1,491
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S2
|
$49,999
|
$1,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-25
|
$5,801,264
|
$116,025
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-06
|
$1,463,426
|
$43,903
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
1P30CA177558-01
|
$1,402,503
|
$14,025
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-01S1
|
$75,000
|
$750
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S1
|
$113,245
|
$4,530
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-14S2
|
$71,639
|
$2,866
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-14
|
$1,063,659
|
$42,546
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S1
|
$25,000
|
$1,500
|
Greenfield, Sheldon
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S2
|
$49,980
|
$2,999
|
Greenfield, Sheldon
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
5P30CA062203-18
|
$1,168,116
|
$70,087
|
Van Etten, Richard
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Tumor-targeted anti-CK2 RNAi for treatment of HCC
|
5R21CA158730-02
|
$148,643
|
$148,643
|
KREN, BETSY
|
UNIVERSITY OF MINNESOTA
|
|
Tumor models for the study of inflammation and oncogenesis
|
ZIA BC 010893
|
$229,994
|
$229,994
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Tumor antigen-specific T-cells and hepatocellular carcinoma
|
1R01CA166111-01A1
|
$332,000
|
$332,000
|
Kaplan, David
|
UNIVERSITY OF PENNSYLVANIA
|
|
TSC2 Localization and Function at the Peroxisome
|
5R01CA143811-04
|
$275,914
|
$275,914
|
WALKER, CHERYL
|
TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
|
|
Transplant cancer match
|
ZIA CP010176-10291
|
$2,959
|
$296
|
Engels, Eric
|
DCEG (NCI)
|
|
Training In Tumor Virology
|
5T32CA115299-08
|
$321,407
|
$64,281
|
Robertson, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
TOR signaling and autophagy in obesity-promoted liver tumorigenesis
|
5R01CA155120-03
|
$331,357
|
$331,357
|
KARIN, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
TLR4 in obesity-driven liver cancer
|
1K22CA178098-01
|
$130,399
|
$130,399
|
Caviglia, Jorge
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
5U10CA045809-25
|
$1,885,277
|
$18,853
|
FISCH, MICHAEL
|
UT MD ANDERSON CANCER CTR
|
|
The transcriptional basis of tumor promotion
|
7R01CA104292-10
|
$313,947
|
$313,947
|
LOCKER, JOSEPH
|
UNIVERSITY OF PITTSBURGH
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$742,894
|
$29,716
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
5R01CA137019-04
|
$273,745
|
$136,873
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Type III TGF-beta Receptor in the Fibrotic Tumor Stroma
|
1F31CA180602-01
|
$33,041
|
$16,521
|
Hesler, Rachel
|
DUKE UNIVERSITY
|
|
The role of the Ras effector Nore1a in tumor suppression
|
5R01CA133171-04
|
$255,419
|
$127,710
|
Clark, Geoffrey
|
UNIVERSITY OF LOUISVILLE RES FDN
|
|
The role of PTEN and AKT2 in the malignant transformation of liver progenitor cel
|
1R01CA154986-01A1
|
$340,300
|
$340,300
|
Stiles, Bangyan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer
|
7R01CA143204-05
|
$222,575
|
$222,575
|
Feng, Zhaohui
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer
|
5R01CA143204-04
|
$75,704
|
$75,704
|
Feng, Zhaohui
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
Total relevant funding to Liver Cancer for this search: $63,977,360
|